Literature DB >> 17989128

A midpoint assessment of the American Cancer Society challenge goal to decrease cancer incidence by 25% between 1992 and 2015.

Rebecca L Sedjo1, Tim Byers, Ermilo Barrera, Carmel Cohen, Elizabeth T H Fontham, Lisa A Newman, Carolyn D Runowicz, Alan G Thorson, Michael J Thun, Elizabeth Ward, Richard C Wender, Harmon J Eyre.   

Abstract

In 1998, the American Cancer Society (ACS) set a challenge goal for the nation to reduce cancer incidence by 25% over the period between 1992 and 2015. This report examines the trends in cancer incidence between 1992 and 2004. Trends were calculated using data on incident malignant cancer cases from the Surveillance, Epidemiology, and End Results (SEER) Registry. Delay-adjusted incidence trends for all cancer sites; all cancer sites without prostate cancer included; all cancer sites stratified by gender, age, and race; and for 20 selected cancer sites are presented. Over the first half of the ACS challenge period, overall cancer incidence rates have declined by about 0.6% per year. The greatest overall declines were observed among men and among those aged 65 years and older. The pace of incidence reduction over the first half of the ACS challenge period was only half that necessary to put us on target to achieve the 25% cancer incidence reduction goal in 2015. New understandings of preventable factors are needed, and new efforts are also needed to better act on our current knowledge about how we can prevent cancer, especially by continuing to reduce tobacco use and beginning to reverse the epidemic of obesity.

Entities:  

Mesh:

Year:  2007        PMID: 17989128     DOI: 10.3322/CA.57.6.326

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  9 in total

1.  Detection of colorectal neoplasia by colonoscopy in average-risk patients age 40-49 versus 50-59 years.

Authors:  Matthew N Thoma; Fernando Castro; Mushfeka Golawala; Ren Chen
Journal:  Dig Dis Sci       Date:  2011-02-01       Impact factor: 3.199

2.  Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.

Authors:  Diego Munoz; Aimee M Near; Nicolien T van Ravesteyn; Sandra J Lee; Clyde B Schechter; Oguzhan Alagoz; Donald A Berry; Elizabeth S Burnside; Yaojen Chang; Gary Chisholm; Harry J de Koning; Mehmet Ali Ergun; Eveline A M Heijnsdijk; Hui Huang; Natasha K Stout; Brian L Sprague; Amy Trentham-Dietz; Jeanne S Mandelblatt; Sylvia K Plevritis
Journal:  J Natl Cancer Inst       Date:  2014-09-24       Impact factor: 13.506

3.  Association between GSTM1 copy number, promoter variants and susceptibility to urinary bladder cancer.

Authors:  Xuemei Zhang; Jie Lin; Xifeng Wu; Zhongning Lin; Baitang Ning; Susan Kadlubar; Fred F Kadlubar
Journal:  Int J Mol Epidemiol Genet       Date:  2012-08-31

4.  Matching colonoscopy and pathology data in population-based registries: development of a novel algorithm and the initial experience of the New Hampshire Colonoscopy Registry.

Authors:  Mary Ann Greene; Lynn F Butterly; Martha Goodrich; Tracy Onega; John A Baron; David A Lieberman; Allen J Dietrich; Amitabh Srivastava
Journal:  Gastrointest Endosc       Date:  2011-06-12       Impact factor: 9.427

5.  Effect of chronic and intermittent calorie restriction on serum adiponectin and leptin and mammary tumorigenesis.

Authors:  Olga P Rogozina; Melissa J L Bonorden; Christine N Seppanen; Joseph P Grande; Margot P Cleary
Journal:  Cancer Prev Res (Phila)       Date:  2011-01-21

6.  A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-κB and generating reactive oxygen species.

Authors:  Rajasubramaniam Shanmugam; Praveen Kusumanchi; Hitesh Appaiah; Liang Cheng; Peter Crooks; Sundar Neelakantan; Tyler Peat; James Klaunig; William Matthews; Harikrishna Nakshatri; Christopher J Sweeney
Journal:  Int J Cancer       Date:  2011-05-15       Impact factor: 7.396

7.  Cancer incidence in the United Kingdom: projections to the year 2030.

Authors:  M Mistry; D M Parkin; A S Ahmad; P Sasieni
Journal:  Br J Cancer       Date:  2011-10-27       Impact factor: 7.640

8.  Effect of Lowering the Blood Alcohol Concentration Limit to 0.03 Among Hospitalized Trauma Patients in Southern Taiwan: A Cross-Sectional Analysis.

Authors:  Chun-Ying Huang; Sheng-En Chou; Wei-Ti Su; Hang-Tsung Liu; Ting-Min Hsieh; Shiun-Yuan Hsu; Hsiao-Yun Hsieh; Ching-Hua Hsieh
Journal:  Risk Manag Healthc Policy       Date:  2020-06-16

9.  Strategies for colon cancer prevention.

Authors:  Jan Björk
Journal:  EPMA J       Date:  2010-09-12       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.